255 related articles for article (PubMed ID: 15836595)
1. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment.
Amir BY; Yaacov B; Guy B; Gad P; Itzhak W; Gal I
Headache; 2005 Mar; 45(3):215-9. PubMed ID: 15836595
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
3. [Estrogen role in the luteal phase support in in vitro fertilization with embryo transfer cycles].
Paredes Chávez FC; Barros Delgadillo JC; Ochoa Rueda SS; Barroso Villa G; Villalobos Acosta S; Sánchez Solís V; Osorio Caballero M; Gaviño Gaviño F
Ginecol Obstet Mex; 2004 Dec; 72():645-55. PubMed ID: 15813475
[TBL] [Abstract][Full Text] [Related]
4. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
5. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis is associated with prevalence of comorbid conditions in migraine.
Tietjen GE; Bushnell CD; Herial NA; Utley C; White L; Hafeez F
Headache; 2007; 47(7):1069-78. PubMed ID: 17635599
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and burden of headache and migraine in Germany.
Radtke A; Neuhauser H
Headache; 2009 Jan; 49(1):79-89. PubMed ID: 19125877
[TBL] [Abstract][Full Text] [Related]
8. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
[TBL] [Abstract][Full Text] [Related]
9. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
[TBL] [Abstract][Full Text] [Related]
10. The effect of retained embryos on pregnancy outcome in an in vitro fertilization and embryo transfer program.
Vicdan K; Işik AZ; Akarsu C; Sözen E; Cağlar G; Dingiloğlu B; Tuncay G
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):79-82. PubMed ID: 17343976
[TBL] [Abstract][Full Text] [Related]
11. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs.
Kelman L; Rains JC
Headache; 2005; 45(7):904-10. PubMed ID: 15985108
[TBL] [Abstract][Full Text] [Related]
12. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
Kably Ambe A; Estévez González S; Carballo Mondragón E
Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
14. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort.
Ertresvåg JM; Zwart JA; Helde G; Johnsen HJ; Bovim G
Acta Neurol Scand; 2005 Apr; 111(4):233-7. PubMed ID: 15740574
[TBL] [Abstract][Full Text] [Related]
15. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of 92 ectopic pregnancy patients after in vitro fertilization and embryo transfer].
Xiao HM; Gong F; Mao ZH; Zhang H; Lu GX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):584-7. PubMed ID: 16951524
[TBL] [Abstract][Full Text] [Related]
17. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
Lukaszuk K; Liss J; Lukaszuk M; Maj B
Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
[TBL] [Abstract][Full Text] [Related]
18. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
19. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.
Mitwally MF; Bhakoo HS; Crickard K; Sullivan MW; Batt RE; Yeh J
Fertil Steril; 2006 Sep; 86(3):588-96. PubMed ID: 16814289
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
